Original Research
Published on 26 Jul 2024
TACE plus lenvatinib and tislelizumab for intermediate-stage hepatocellular carcinoma beyond up-to-11 criteria: a multicenter cohort study
in Cancer Immunity and Immunotherapy
![TACE plus lenvatinib and tislelizumab for intermediate-stage hepatocellular carcinoma beyond up-to-11 criteria: a multicenter cohort study](https://www.frontiersin.org/files/myhome article library/1430571/1430571_Thumb_400.jpg)
Original Research
Published on 26 Jul 2024
in Cancer Immunity and Immunotherapy
Original Research
Published on 26 Jul 2024
in Agroecology and Ecosystem Services
Original Research
Published on 26 Jul 2024
in Intensive Care Medicine and Anesthesiology
Original Research
Published on 26 Jul 2024
in Virtual Reality and Human Behaviour
Original Research
Published on 26 Jul 2024
in Geohazards and Georisks
Mini Review
Published on 26 Jul 2024
in Molecular Diagnostics and Therapeutics
Original Research
Published on 26 Jul 2024
in Life-Course Epidemiology and Social Inequalities in Health
Review
Published on 26 Jul 2024
in Obstetrics and Gynecology
Editorial
Published on 26 Jul 2024
in Polymeric and Composite Materials
Original Research
Published on 26 Jul 2024
in Nutrition Methodology
Review
Published on 26 Jul 2024
in Cellular Neurophysiology
Original Research
Published on 26 Jul 2024
in Experimental Pharmacology and Drug Discovery
Original Research
Published on 26 Jul 2024
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 26 Jul 2024
in Gastroenterology
Original Research
Published on 26 Jul 2024
in Translational Medicine
Review
Published on 26 Jul 2024
in Structural Interventional Cardiology